‘Where we are today in biology AI is similar to GPT in 2020’: An interview with the CEO of Africa’s biggest AI startup
SMRTR summary
BioNTech's $550 million Instadeep buyout has turbocharged their AI-driven biotech efforts, speeding up processes, creating new protein analysis models, and launching a supercomputer, while Instadeep keeps tackling industrial optimization projects beyond biotech.
SMRTR provides this summary for quick context. The original article belongs to Daily.dev.
Read the original article